bibliographic entry 12414292 [be/12414292]
https://w3id.org/oc/corpus/be/12414292

is a

• bibliographic reference

content

• Schlumberger, M, Tahara, M, Wirth, L. J, Robinson, B, Brose, M. S, Elisei, R, … Sherman, S. I. (2014). A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT) [abstract]. In Journal of clinical oncology: official journal of the American Society of Clinical Oncology (p. LBA6008).

references

• https://w3id.org/oc/corpus/br/8212791